IL35334A - Potentiation of antibiotics of the phosphonomycin series - Google Patents

Potentiation of antibiotics of the phosphonomycin series

Info

Publication number
IL35334A
IL35334A IL35334A IL3533470A IL35334A IL 35334 A IL35334 A IL 35334A IL 35334 A IL35334 A IL 35334A IL 3533470 A IL3533470 A IL 3533470A IL 35334 A IL35334 A IL 35334A
Authority
IL
Israel
Prior art keywords
phosphonomycin
bacteria
antibiotics
potentiation
series
Prior art date
Application number
IL35334A
Other languages
English (en)
Other versions
IL35334A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL35334A0 publication Critical patent/IL35334A0/xx
Publication of IL35334A publication Critical patent/IL35334A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL35334A 1969-10-02 1970-09-22 Potentiation of antibiotics of the phosphonomycin series IL35334A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86335169A 1969-10-02 1969-10-02
US7124770A 1970-09-11 1970-09-11

Publications (2)

Publication Number Publication Date
IL35334A0 IL35334A0 (en) 1971-04-28
IL35334A true IL35334A (en) 1974-01-14

Family

ID=26752007

Family Applications (1)

Application Number Title Priority Date Filing Date
IL35334A IL35334A (en) 1969-10-02 1970-09-22 Potentiation of antibiotics of the phosphonomycin series

Country Status (7)

Country Link
BE (1) BE756953A (enrdf_load_stackoverflow)
CA (1) CA943067A (enrdf_load_stackoverflow)
DE (1) DE2048375A1 (enrdf_load_stackoverflow)
FR (1) FR2070104B1 (enrdf_load_stackoverflow)
GB (1) GB1311956A (enrdf_load_stackoverflow)
IL (1) IL35334A (enrdf_load_stackoverflow)
NL (1) NL7014541A (enrdf_load_stackoverflow)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660305A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
CH660306A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
GB2299025B (en) * 1992-03-17 1996-11-27 British Tech Group Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye
GEP20084540B (en) 2003-01-14 2008-11-25 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
PH12013500547A1 (en) 2010-09-22 2013-06-10 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
FI3242666T3 (fi) 2015-01-06 2024-12-16 Arena Pharm Inc Menetelmiä s1p1-reseptoriin liittyvien sairauksien hoitamiseksi
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. S1p1 수용체-관련 장애에서의 사용을 위한 (r)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[b]인돌-3-일)아세트산 (화합물 1)의 결정성 l-아르기닌 염
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体に関連する状態を治療する方法

Also Published As

Publication number Publication date
FR2070104A1 (enrdf_load_stackoverflow) 1971-09-10
CA943067A (en) 1974-03-05
GB1311956A (en) 1973-03-28
BE756953A (fr) 1971-04-01
DE2048375A1 (de) 1971-04-22
FR2070104B1 (enrdf_load_stackoverflow) 1974-02-22
IL35334A0 (en) 1971-04-28
NL7014541A (enrdf_load_stackoverflow) 1971-04-06

Similar Documents

Publication Publication Date Title
IL35334A (en) Potentiation of antibiotics of the phosphonomycin series
CA924973A (en) Drinking valve for poultry and livestock
ES411065A1 (es) Un procedimiento para la preparacion de acidos 6-(alfa-ome-ga-guanidicroalcanoilaenidonacilamido) penicilanicos.
GB1220133A (en) Improvements in or relating to refrigeration systems
CA931954A (en) Derivatives of 2,4,6-triiodobenzoic acid
GB1124777A (en) Mechanical seal construction
CA710830A (en) Disodium and calcium salt of the calcium complex of 2-aminocyclohexyl 2'-aminoethyl ether-n,n,n',n'-tetraacetic acid
GB1255891A (en) Cyclopentapyrimidine derivative
CA919189A (en) 3,5-dihydrocarbyl-4-hydroxyphenyl phosphites, phosphates or phosphothionates and their use as antioxidants
GB1388179A (en) Benzylpyrimidine derivatives
CA813286A (en) Nutriment compositions containing 3,6-pyridazine-diol or organotropic salts thereof
GB1175590A (en) Therapeutic Compositions
FR2059968A1 (en) Effervescent tetracycline compositions
GB1264389A (enrdf_load_stackoverflow)
CA957282A (en) ANTI-INFLAMATORY COMPOSITION CONTAINING .gamma.-OXO-2-DIBENZOFURANBUTYRIC ACID
CA822728A (en) Phosphonate stabilized nylon compositions
CA920868A (en) Animal nutrients
CA819070A (en) Animal food supplement
AU440635B2 (en) Animal oiler
CA842165A (en) Ruminant nutrient compositions
CA805124A (en) Agricultural antimicrobial compositions and process for utilizing same
CA938830A (en) Three-point hitch
AU6062569A (en) Rumen stable medicament and/or nutrient compositions
CA807150A (en) Erythromycin phosphate
CA857907A (en) O,o-dialkyl phosphorodithioate and phosphorothioate esters containing the hydantoin nucleus and insecticide compositions containing the same